CABG Versus PCI Greater Benefit in Long-Term Outcomes with Multiple Arterial Bypass Grafting Presented in part as an oral Plenary Session presentation at the American Association for Thoracic Surgeons Meeting, April 26 to 30, 2014, Toronto, Canada.

Journal of the American College of Cardiology

Volumn 66, Issue 13, 2015, Pages 1417-1427

  Habib, Robert H ^a   Dimitrova, Kamellia R ^b   Badour, Sanaa A ^a   Yammine, Maroun B ^a   El Hage Sleiman, Abdul Karim M ^a   Hoffman, Darryl M ^b   Geller, Charles M ^b   Schwann, Thomas A ^c   Tranbaugh, Robert F ^b  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b BETH ISRAEL MEDICAL CENTER   (United States)

^c MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

arterial grafting; coronary stents; myocardial revascularization; propensity matching

Indexed keywords

ADULT; AGED; ARTICLE; BARE METAL STENT; CARDIOVASCULAR MORTALITY; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; DRUG ELUTING CORONARY STENT; EVEROLIMUS ELUTING CORONARY STENT; EVIDENCE BASED MEDICINE; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; INTERMETHOD COMPARISON; INTERVENTION STUDY; KAPLAN MEIER METHOD; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PACLITAXEL ELUTING CORONARY STENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REOPERATION; SEX RATIO; SIROLIMUS ELUTING CORONARY STENT; SURGICAL MORTALITY; SURVIVAL RATE; SURVIVAL TIME; ZOTAROLIMUS ELUTING CORONARY STENT; COMPARATIVE STUDY; CORONARY BLOOD VESSEL; MIDDLE AGED; MORTALITY; PATHOLOGY; PROCEDURES; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; TIME; TREATMENT OUTCOME; TRENDS;

AGED; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; CORONARY VESSELS; FEMALE; HUMANS; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84942083668     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2015.07.060     Document Type: Article

References (36)

1. P.W. Serruys, A.T. Ong, L.A. van Herwerden, and et al. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial J Am Coll Cardiol 46 2005 575 581
2. W. Hueb, N.H. Lopes, B.J. Gersh, and et al. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease Circulation 115 2007 1082 1089
3. J. Booth, T. Clayton, J. Pepper, et al. for the SoS Investigators Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease: six-year follow-up from the Stent or Surgery Trial (SoS) Circulation 118 2008 381 388
4. A. Kapur, R.J. Hall, I.S. Malik, and et al. Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients: 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial J Am Coll Cardiol 55 2010 432 440
5. A.P. Kappetein, T.E. Feldman, M.J. Mack, and et al. Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial Eur Heart J 32 2011 2125 2134
6. M.E. Farkouh, M. Domanski, L.A. Sleeper, et al. for the FREEDOM Trial Investigators Strategies for multivessel revascularization in patients with diabetes N Engl J Med 367 2012 2375 2384
7. D.P. Taggart Thomas B. Ferguson Lecture. Coronary artery bypass grafting is still the best treatment for multivessel and left main disease, but patients need to know Ann Thorac Surg 82 2006 1966 1975
8. E.L. Hannan, C. Wu, G. Walford, and et al. Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease N Engl J Med 358 2008 331 341
9. E.L. Hannan, M.J. Racz, G. Walford, and et al. Long-term outcomes of coronary-artery bypass grafting versus stent implantation N Engl J Med 352 2005 2174 2183
10. C. Wu, F.T. Camacho, S. Zhao, and et al. Long-term mortality of coronary artery bypass graft surgery and stenting with drug-eluting stents Ann Thorac Surg 95 2013 1297 1305
11. C. Spaulding, J. Daemen, E. Boersma, D.E. Cutlip, and P.W. Serruys A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents N Engl J Med 356 2007 989 997
12. M. Natsuaki, T. Morimoto, Y. Furukawa, et al. for the CREDO-Kyoto PCI/CABG Registry Cohort-2 Investigators Late adverse events after implantation of sirolimus-eluting stent and bare-metal stent: long-term (5-7 years) follow-up of the Coronary Revascularization Demonstrating Outcome study-Kyoto registry Cohort-2 Circ Cardiovasc Interv 7 2014 168 179
13. S. Verma, M.E. Farkouh, B. Yanagawa, and et al. Comparison of coronary artery bypass surgery and percutaneous coronary intervention in patients with diabetes: a meta-analysis of randomized controlled trials Lancet Diabetes Endocrinol 1 2013 317 328
14. W.S. Weintraub, M.V. Grau-Sepulveda, J.M. Weiss, and et al. Comparative effectiveness of revascularization strategies N Engl J Med 366 2012 1467 1476
15. Y.G. Kim, D.W. Park, W.S. Lee, and et al. Influence of diabetes mellitus on long-term (five-year) outcomes of drug-eluting stents and coronary artery bypass grafting for multivessel coronary revascularization Am J Cardiol 109 2012 1548 1557
16. B.W. Lytle, E.H. Blackstone, J.F. Sabik, P. Houghtaling, F.D. Loop, and D.M. Cosgrove The effect of bilateral internal thoracic artery grafting on survival during 20 postoperative years Ann Thorac Surg 78 2004 2005 2012
17. A. Zacharias, R.H. Habib, T.A. Schwann, C.J. Riordan, S.J. Durham, and A. Shah Improved survival with radial artery versus vein conduits in coronary bypass surgery with left internal thoracic artery to left anterior descending artery grafting Circulation 109 2004 1489 1496
18. J.S. Rankin, R.H. Tuttle, A.S. Wechsler, T.L. Teichmann, D.D. Glower, and R.M. Califf Techniques and benefits of multiple internal mammary artery bypass at 20 years of follow-up Ann Thorac Surg 83 2007 1008 1014
19. A. Zacharias, T.A. Schwann, C.J. Riordan, S.J. Durham, A.S. Shah, and R.H. Habib Late results of conventional versus all-arterial revascularization based on internal thoracic and radial artery grafting Ann Thorac Surg 87 2009 19 26.e2
20. T.A. Schwann, A. Zacharias, C.J. Riordan, S.J. Durham, A.S. Shah, and R.H. Habib Sequential radial artery grafts for multivessel coronary artery bypass graft surgery: 10-year survival and angiography results Ann Thorac Surg 88 2009 31 39
21. P.A. Kurlansky, E.A. Traad, M.J. Dorman, D.L. Galbut, M. Zucker, and G. Ebra Thirty-year follow-up defines survival benefit for second internal mammary artery in propensity-matched groups Ann Thorac Surg 90 2010 101 108
22. R.F. Tranbaugh, K.R. Dimitrova, P. Friedmann, and et al. Radial artery conduits improve long-term survival after coronary artery bypass grafting Ann Thorac Surg 90 2010 1165 1172
23. A. Zacharias, T.A. Schwann, C.J. Riordan, and et al. Late outcomes after radial artery versus saphenous vein grafting during reoperative coronary artery bypass surgery J Thorac Cardiovasc Surg 139 2010 1511 1518.e4
24. J.D. Puskas, A. Sadiq, T.A. Vassiliades, P.D. Kilgo, and O.M. Lattouf Bilateral internal thoracic artery grafting is associated with significantly improved long-term survival, even among diabetic patients Ann Thorac Surg 94 2012 710 715
25. R.H. Habib, T.A. Schwann, and M. Engoren Late effects of radial artery versus saphenous vein grafting in patients aged 70 years or older Ann Thorac Surg 94 2012 1478 1484
26. T.A. Schwann, M. Engoren, M. Bonnell, C. Clancy, and R.H. Habib Comparison of late coronary artery bypass graft survival effects of radial artery versus saphenous vein grafting in male and female patients Ann Thorac Surg 94 2012 1485 1491
27. T.A. Schwann, L. Al-Shaar, M. Engoren, and R.H. Habib Late effects of radial artery vs saphenous vein grafting for multivessel coronary bypass surgery in diabetics: a propensity-matched analysis Eur J Cardiothorac Surg 44 2013 701 710
28. T.A. Schwann, R.F. Tranbaugh, K.R. Dimitrova, and et al. Time-varying survival benefit of radial artery versus vein grafting: a multiinstitutional analysis Ann Thorac Surg 97 2014 1328 1334
29. B.F. Buxton, W.Y. Shi, J. Tatoulis, J.A. Fuller, A. Rosalion, and P.A. Hayward Total arterial revascularization with internal thoracic and radial artery grafts in triple-vessel coronary artery disease is associated with improved survival J Thorac Cardiovasc Surg 148 2014 1238 1243
30. P.C. Austin Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research Commun Stat Simul Comput 38 2009 1228 1234
31. D.P. Taggart CABG or stents in coronary artery disease: end of the debate? Lancet 381 2013 605 607
32. D.J. Cohen, R.L. Osnabrugge, E.A. Magnuson, et al. for the SYNTAX Trial Investigators Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial Circulation 130 2014 1146 1157
33. J. Tatoulis, B.F. Buxton, and J.A. Fuller The right internal thoracic artery: the forgotten conduit - 5,766 patients and 991 angiograms Ann Thorac Surg 92 2011 9 15
34. J.H. Alexander, G. Hafley, R.A. Harrington, et al. for the PREVENT IV Investigators Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial JAMA 294 2005 2446 2454
35. K.R. Dimitrova, D.M. Hoffman, C.M. Geller, G. Dincheva, W. Ko, and R.F. Tranbaugh Arterial grafts protect the native coronary vessels from atherosclerotic disease progression Ann Thorac Surg 94 2012 475 481
36. P.A. Hayward, Y.Y. Zhu, T.T. Nguyen, D.L. Hare, and B.F. Buxton Should all moderate coronary lesions be grafted during primary coronary bypass surgery? An analysis of progression of native vessel disease during a randomized trial of conduits J Thorac Cardiovasc Surg 145 2013 140 148